Vera Therapeutics (VERA) Other Operating Expenses (2021 - 2022)
Vera Therapeutics (VERA) posted Other Operating Expenses of $16.0 million for Q3 2022, up 492.94% on a QoQ basis from $2.7 million in Q2 2021.
Vera Therapeutics (VERA) Other Operating Expenses (2021 - 2022) Analysis & Trends
Vera Therapeutics' Other Operating Expenses history runs 2 years deep, the most recent figure standing at $16.0 million for Q3 2022.
- Quarterly Other Operating Expenses changed N/A year-over-year to $16.0 million in Q3 2022, while the trailing twelve-month figure through Jun 2023 was $16.0 million (changed N/A YoY) and the FY2021 annual result came in at $2.7 million, changed N/A from the prior year.
- Other Operating Expenses was $16.0 million for Q3 2022 at Vera Therapeutics, up from $2.7 million in the prior quarter.
- Across five years, Other Operating Expenses topped out at $16.0 million in Q3 2022 and bottomed at $2.7 million in Q2 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Vera Therapeutics | 2.55 Bn | 2.55 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | 15.96 Mn |
| Jun 30, 2021 | 2.69 Mn |